GWest Corporation Limited (JMSE:GWEST)

Ligand Pharmaceuticals Revenue

In the fiscal year ending March 31, 2025, GWest Corporation had annual revenue of 267.94M JMD, down -3.30%. GWest Corporation had revenue of 65.39M in the quarter ending March 31, 2025, a decrease of -32.08%.

• Revenue: 267.94M
• Revenue Growth: -3.30%
• P/S Ratio: 1.79
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 480.00M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2025	267.94M	-9.15M	-3.30%
Mar 31, 2024	277.10M	79.64M	40.34%
Mar 31, 2023	197.45M	51.16M	34.98%
Mar 31, 2022	146.29M	33.19M	29.35%
Mar 31, 2021	113.10M	-16.00M	-12.40%